10times
19 - 20 Oct 2020Ended

Microbiome Movement - Drug Development Summit

About 30Sessions 65SpeakersExhibitorsReviewsPhotos

Estimated Turnout

100 - 500
Delegates
Based on previous editions

Editions

19 - 20 Oct 2020

Frequency

Not Available
Claim event to edit details

Our digital platform creates an experience that closely mimics the face-to-face event experience, showcasing live Q&A, interactive breakout discussions, digital speed networking and 1-2-1 private messaging with other attendees.

2   Different Located Editions
Boston, USA 19 - 21 Oct 2020
15 Followers
Singapore 17 - 18 Sep 2019
9 Followers
Filter By
Mon, 19 Oct
Session
Microbiome Leaders Panel Discussion
Mon, 19 Oct
Session
Gut Microbiome Endgame: Ramping up cGMP Program Design to Ensure Regulatory Preparedness for Microbiome Products
Mon, 19 Oct
Session
Shotgun Sequencing & Strain-Level Analysis: Study Design for Pre-Clinical & Clinical Development
Mon, 19 Oct
Break
Morning Break & Virtual Speed Networking
Mon, 19 Oct
Session
Track A: Pre-Clinical Development & Mechanistic Analysis of Microbiome-based Therapeutics
Mon, 19 Oct
Session
Track B: Clinical Translation, Manufacturing and Commercialization of Microbiome-based Therapeutics
Mon, 19 Oct
Session
Track C: Microbiome-based Biomarkers, Bioinformatics and Patient Stratification
Mon, 19 Oct
Lunch
Lunch and Networking
Mon, 19 Oct
Session
Microbiome Chemistry Small Molecules
Mon, 19 Oct
Session
Designing and Executing Clinical Trials – A Clinician’s Perspective
Mon, 19 Oct
Session
Biomarker Applications in Drug Discovery and Patient Stratification
Mon, 19 Oct
Break
Afternoon Break & Virtual Speed Networking
Mon, 19 Oct
Session
Track A: Pre-Clinical Development & Mechanistic Analysis of Microbiome-based Therapeutics
Mon, 19 Oct
Session
Track B: Clinical Translation, Manufacturing and Commercialization of Microbiome-based Therapeutics
Mon, 19 Oct
Session
Track C: Microbiome-based Biomarkers, Bioinformatics and Patient Stratification
Mon, 19 Oct

Close of Conference Day One
Tue, 20 Oct
Session
Regulatory and Clinical Considerations for LBPs
Tue, 20 Oct
Session
Updates from the Microbiome Therapeutics Innovation Group (MTIG)
Tue, 20 Oct
Session
Advances in Meeting the Microbiome Supply Needs
Tue, 20 Oct
Session
A Trifecta in Microbiome Advancements: Expectations from the Partnership of Diversigen, Corebiome and DNA Genotek
Tue, 20 Oct
Break
Morning Break & Networking
Tue, 20 Oct
Session
Track A: Pre-Clinical Development & Mechanistic Analysis of Microbiome-based Therapeutics
Tue, 20 Oct
Session
Track B: Clinical Translation, Manufacturing and Commercialization of Microbiome-based Therapeutics
Tue, 20 Oct
Session
Track C: Microbiome-based Biomarkers, Bioinformatics and Patient Stratification
Tue, 20 Oct
Lunch
Lunch and Networking
Tue, 20 Oct
Session
Subtractive Therapeutics that Target the Human Microbiome
Tue, 20 Oct
Session
Defining Alternative Clinical Pathways to Microbiome-based Therapeutics
Tue, 20 Oct
Session
Challenges of Bioinformatics & Data Integration
Tue, 20 Oct
Session
Designing and Executing FMT Clinical Trials
Tue, 20 Oct

Close of 5th Microbiome Movement – Drug Development Summit 2020
Speaker
Deepak Gopalakrishnan

Deepak Gopalakrishnan

Scientist - Microbiome Discovery
Speaker
Marcus Rauch

Marcus Rauch

Chief Scientific Officer
Speaker
Mark Bamforth

Mark Bamforth

President & CEO
Speaker
Jackie Papkoff

Jackie Papkoff

Chief Scientific Officer
Visitor/General
1999 USD Drug Developer
1199 USD Academic, Start-Up & Not-For Profit
2699 USD Solution Provider
  • Followers
  • [ Users who have shown interest for this Event ]
zahra

zahra

Student at student

Toronto, Canada
  • Share your Experience
  • Organizer
Logo Follow Company

Hanson Wade Limited

UK 340 Total Events / 97 Upcoming Events 79+ Followers

More Events From The Organizer